Could a drug boost brain stimulation for stubborn depression?
NCT ID NCT07227103
First seen Nov 12, 2025 · Last updated May 23, 2026 · Updated 26 times
Summary
This study tests whether adding the drug NRX-101 to transcranial magnetic stimulation (TMS) helps people with treatment-resistant depression more than TMS alone. About 120 adults will receive either NRX-101 or a placebo alongside TMS, and researchers will measure changes in depression and suicidal thoughts after six weeks. The goal is to see if the combination leads to higher response and remission rates.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cohen and Associates
Sarasota, Florida, 34239, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.